Bonviva 3 mg/3 mL Injection contains ibandronic acid, a bisphosphonate used to treat osteoporosis in postmenopausal women, reducing the risk of vertebral fractures./Description: Bonviva Injection is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures. The active ingredient, ibandronic acid, inhibits osteoclast activity, reducing bone resorption and turnover, leading to a net gain in bone mass. Clinical studies have demonstrated its efficacy in reducing the incidence of new vertebral fractures.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
